• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Manning & Napier Inc.

    10/21/22 10:46:57 AM ET
    $MN
    Investment Managers
    Finance
    Get the next $MN alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-35355
    Issuer: Manning & Napier, Inc.
    Exchange: NEW YORK STOCK EXCHANGE LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 290 Woodcliff Drive
    Fairport NEW YORK 14450
    Telephone number: (585) 325-6880
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Class A Common Stock
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2022-10-21 By Daniel Contrastano Manager, Market Watch & Proxy Compliance
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $MN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Callodine Group Completes Take Private Acquisition of Manning & Napier, Inc.

      FAIRPORT, N.Y., Oct. 21, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced the completion of its process to go private and be acquired by Callodine Group LLC ("Callodine"), a Boston-based asset management firm. The transaction was announced on April 1, 2022 and received shareholder approval on August 3, 2022. Under the terms of the go-private transaction, Manning & Napier stockholders will receive $12.85 per share in cash. With the completion of the acquisition, Manning & Napier's common stock has ceased trading and will no longer be listed on the New York Stock Exchange. "We are excited to complete the acquisition of Manning & Napie

      10/21/22 8:58:00 AM ET
      $MN
      Investment Managers
      Finance
    • Manning & Napier, Inc. Reports September 30, 2022 Assets Under Management

      FAIRPORT, N.Y., Oct. 12, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today reported preliminary assets under management ("AUM") as of September 30, 2022 of $17.4 billion, which included approximately $12.4 billion in separately managed accounts and approximately $5.0 billion in mutual funds and collective investment trusts. Transaction Update As previously announced, Manning & Napier expects to complete its transaction with Callodine Group in October 2022. About Manning & Napier, Inc. Manning & Napier (NYSE:MN) provides a broad range of investment solutions through separately managed accounts, mutual funds, and collective investment trust fund

      10/12/22 4:05:00 PM ET
      $MN
      Investment Managers
      Finance
    • Manning & Napier, Inc. Transaction Update

      FAIRPORT, N.Y., Sept. 28, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced the extension of the outside date under the merger agreement with Callodine Group LLC ("Callodine") to December 1, 2022. "We continue to work diligently to conclude the regulatory review processes necessary to close our transaction," said Marc Mayer, Chairman and CEO of Manning & Napier. "In order to continue to productively engage with the regulators, we have revised our outlook and now expect the transaction to close in October 2022. We appreciate the continued support of our employees, clients and shareholders and look forward to the Company's next chapter

      9/28/22 4:05:00 PM ET
      $MN
      Investment Managers
      Finance

    $MN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Manning & Napier Inc. (Amendment)

      SC 13G/A - Manning & Napier, Inc. (0001524223) (Subject)

      2/13/23 12:54:51 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form SC 13D/A filed by Manning & Napier Inc. (Amendment)

      SC 13D/A - Manning & Napier, Inc. (0001524223) (Subject)

      10/26/22 3:56:32 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form SC 13G/A filed by Manning & Napier Inc. (Amendment)

      SC 13G/A - Manning & Napier, Inc. (0001524223) (Subject)

      6/8/22 10:44:24 AM ET
      $MN
      Investment Managers
      Finance

    $MN
    SEC Filings

    See more
    • SEC Form EFFECT filed by Manning & Napier Inc.

      EFFECT - Manning & Napier, Inc. (0001524223) (Filer)

      11/1/22 12:15:07 AM ET
      $MN
      Investment Managers
      Finance
    • SEC Form 15-12G filed by Manning & Napier Inc.

      15-12G - Manning & Napier, Inc. (0001524223) (Filer)

      10/31/22 4:01:31 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form S-8 POS filed by Manning & Napier Inc.

      S-8 POS - Manning & Napier, Inc. (0001524223) (Filer)

      10/27/22 4:31:58 PM ET
      $MN
      Investment Managers
      Finance

    $MN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Goodstein Barbara returned $2,285,347 worth of shares to the company (177,848 units at $12.85), closing all direct ownership in the company

      4 - Manning & Napier, Inc. (0001524223) (Issuer)

      10/26/22 4:48:22 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form 4: Pettinella Edward J returned $6,930,236 worth of shares to the company (539,318 units at $12.85), closing all direct ownership in the company

      4 - Manning & Napier, Inc. (0001524223) (Issuer)

      10/26/22 4:46:23 PM ET
      $MN
      Investment Managers
      Finance
    • SEC Form 4: Marvald Kenneth A returned $1,682,913 worth of shares to the company (130,966 units at $12.85), closing all direct ownership in the company

      4 - Manning & Napier, Inc. (0001524223) (Issuer)

      10/26/22 4:45:40 PM ET
      $MN
      Investment Managers
      Finance

    $MN
    Financials

    Live finance-specific insights

    See more
    • Manning & Napier, Inc. Reports Second Quarter 2022 Earnings Results

      FAIRPORT, N.Y., Aug. 9, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or the "Company") today reported 2022 second quarter results for the period ended June 30, 2022. "Broad and significant declines across capital markets globally continued in the second quarter, pressuring revenues and causing mark-to-market declines in securities held on the balance sheet," commented Marc Mayer, Chairman of the Board and Chief Executive Officer of Manning & Napier. "We are managing our expenses thoughtfully and we are entirely focused on delivering excellent results and superior service for our clients." Mr. Mayer added, "We are progressing toward the completion of our previous

      8/9/22 8:00:00 AM ET
      $MN
      Investment Managers
      Finance
    • Manning & Napier, Inc. Announces Quarterly Dividend

      FAIRPORT, N.Y., July 22, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced that its Board of Directors has declared a quarterly dividend of $0.05 per share of Class A common stock. The dividend will be paid on or about August 19, 2022 to shareholders of record as of the close of business on August 5, 2022.  About Manning & Napier, Inc.Manning & Napier (NYSE:MN) provides a broad range of investment solutions through separately managed accounts, mutual funds, and collective investment trust funds, as well as a variety of consultative services that complement our investment process. Founded in 1970, we offer equity, fixed income and alt

      7/22/22 8:00:00 AM ET
      $MN
      Investment Managers
      Finance
    • Manning & Napier, Inc. to Report Second Quarter Results; Announces June 30, 2022 Assets Under Management

      FAIRPORT, N.Y., July 13, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced that it expects to release its second quarter 2022 financial results the week of August 8th, 2022, in conjunction with its related 10-Q filing. In light of the previously announced definitive agreement to be acquired by Callodine Group, the Company will not host a conference call to discuss second quarter 2022 financial results. Assets Under ManagementThe Company also announced that preliminary June 30, 2022 assets under management ("AUM") were $18.5 billion, which included approximately $13.3 billion in separately managed accounts and approximately $5.2 billi

      7/13/22 4:05:00 PM ET
      $MN
      Investment Managers
      Finance

    $MN
    Leadership Updates

    Live Leadership Updates

    See more
    • Lakeland Industries Appoints Investment Industry Veteran Nikki Hamblin to Board of Directors

      DECATUR, AL / ACCESSWIRE / February 24, 2021 / Lakeland Industries, Inc. (NASDAQ:LAKE) (the "Company" or "Lakeland"), a leading global manufacturer of protective clothing for industry, healthcare and to first responders on the federal, state and local levels, today announced the appointment of investment industry veteran Nikki Hamblin to its Board of Directors (the "Board"). The appointment increases the number of directors to seven, five of whom are independent. Christopher J. Ryan, Executive Chairman of Lakeland Industries, commented, "We are pleased to have Nikki join our Board to enhance our sound governance and solid succession planning. Her appointment and the increased size of our Bo

      2/24/21 9:00:00 AM ET
      $MN
      $LAKE
      Investment Managers
      Finance
      Industrial Specialties
      Health Care